ABN AMRO BANK N.V.
FORM 38.5(a)
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS
WITH RECOGNISED INTERMEDIARY STATUS
DEALING IN A CLIENT-SERVING CAPACITY
(Rule 38.5(a) of the Takeover Code)1. KEY INFORMATION Name of exempt principal trader ABN AMRO BANK N.V. London Branch
---------------------------------------------------------------------------------------------------------
Company dealt in NeuTec Pharma Plc (NTP.L)
---------------------------------------------------------------------------------------------------------
Class of relevant security to which the ORD 0.25 GBP
dealings being disclosed relate (Note 1)
---------------------------------------------------------------------------------------------------------
Date of dealing 30th June 2006
--------------------------------------------------------------------------------------------------------- 2. DEALINGS (Note 2) (a) Purchases and sales Total number of securities Highest price paid (Note 3) Lowest price paid (Note
3)
purchased
---------------------------------------------------------------------------------------------------------
8,000 10.4400 GBP 10.4400 GBP
--------------------------------------------------------------------------------------------------------- Total number of securities sold Highest price received (Note 3) Lowest price received
(Note 3)
--------------------------------------------------------------------------------------------------------- (b) Derivatives transactions (other than options) Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit
(Note 3)
e.g. CFD
-------------------------------------------------------------------------------------------------------- (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, Number of Exercise Type, e.g. Expiry Option
money
e.g. call option selling, securities to price American, date
paid/received
purchasing, which the option European per
unit (Note
varying etc. relates (Note 5) etc. 3)
-------------------------------------------------------------------------------------------------------(ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit
(Note 3)
--------------------------------------------------------------------------------------------------------- 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and
any other
person relating to the voting rights of any relevant securities under any option referred to
on this
form or relating to the voting rights or future acquisition or disposal of any relevant
securities to
which any derivative referred to on this form is referenced. If none, this should be stated. --------------------------------------------------------------------------------------------------------- Date of disclosure 03rd July 2006
---------------------------------------------------------------------------------------------------------
Contact name Kirit Devshi
---------------------------------------------------------------------------------------------------------
Telephone number 020 7678 1904
---------------------------------------------------------------------------------------------------------
Name of offeree/offeror with which connected NeuTec Pharma Plc
---------------------------------------------------------------------------------------------------------
Nature of connection (Note 6) Advisor
--------------------------------------------------------------------------------------------------------- Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
|